These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30837696)

  • 1. Engineering advanced cancer therapies with synthetic biology.
    Wu MR; Jusiak B; Lu TK
    Nat Rev Cancer; 2019 Apr; 19(4):187-195. PubMed ID: 30837696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic biology approaches for improving the specificity and efficacy of cancer immunotherapy.
    Zhu B; Yin H; Zhang D; Zhang M; Chao X; Scimeca L; Wu MR
    Cell Mol Immunol; 2024 May; 21(5):436-447. PubMed ID: 38605087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic mammalian gene circuits for biomedical applications.
    Ye H; Aubel D; Fussenegger M
    Curr Opin Chem Biol; 2013 Dec; 17(6):910-7. PubMed ID: 24466575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic therapeutic gene circuits in mammalian cells.
    Ye H; Fussenegger M
    FEBS Lett; 2014 Aug; 588(15):2537-44. PubMed ID: 24844435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic biology approaches in cancer immunotherapy, genetic network engineering, and genome editing.
    Chakravarti D; Cho JH; Weinberg BH; Wong NM; Wong WW
    Integr Biol (Camb); 2016 Apr; 8(4):504-17. PubMed ID: 27068224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SYNTHETIC BIOLOGY. Customizing cell-cell communication.
    Vogt N
    Nat Methods; 2016 Apr; 13(4):285. PubMed ID: 27482567
    [No Abstract]   [Full Text] [Related]  

  • 7. T cell engineering as therapy for cancer and HIV: our synthetic future.
    June CH; Levine BL
    Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140374. PubMed ID: 26416683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programming gene and engineered-cell therapies with synthetic biology.
    Kitada T; DiAndreth B; Teague B; Weiss R
    Science; 2018 Feb; 359(6376):. PubMed ID: 29439214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial Antigen Targeting: Ideal T-Cell Sensing and Anti-Tumor Response.
    Themeli M; Sadelain M
    Trends Mol Med; 2016 Apr; 22(4):271-273. PubMed ID: 26971630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering Microorganisms for Cancer Immunotherapy.
    Liu D; Yu L; Rong H; Liu L; Yin J
    Adv Healthc Mater; 2024 Jul; 13(18):e2304649. PubMed ID: 38598792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Receptor for All Occasions.
    Irvine DJ
    Cell; 2016 Feb; 164(4):599-600. PubMed ID: 26871625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yeasts encoding tumour antigens in cancer immunotherapy.
    Franzusoff A; Duke RC; King TH; Lu Y; Rodell TC
    Expert Opin Biol Ther; 2005 Apr; 5(4):565-75. PubMed ID: 15934834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foundations and Emerging Paradigms for Computing in Living Cells.
    Ma KC; Perli SD; Lu TK
    J Mol Biol; 2016 Feb; 428(5 Pt B):893-915. PubMed ID: 26908220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [T Lymphocytes with Modified Specificity in the Therapy of Malignant Diseases].
    Vdovin AS; Bykova NA; Efimov GA
    Mol Biol (Mosk); 2017; 51(6):1008-1023. PubMed ID: 29271964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cancer-immunity cycle as rational design for synthetic cancer drugs: Novel DC vaccines and CAR T-cells.
    Ramachandran M; Dimberg A; Essand M
    Semin Cancer Biol; 2017 Aug; 45():23-35. PubMed ID: 28257957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody Therapies in Cancer.
    Wang S; Jia M
    Adv Exp Med Biol; 2016; 909():1-67. PubMed ID: 27240456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell engineering for tumor immunotherapy: from biology to clinical translation.
    Bhargava A; Mishra D; Banerjee S; Mishra PK
    Immunotherapy; 2012 Jul; 4(7):703-18. PubMed ID: 22853757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic biology in cell-based cancer immunotherapy.
    Chakravarti D; Wong WW
    Trends Biotechnol; 2015 Aug; 33(8):449-61. PubMed ID: 26088008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programming Surface Chemistry with Engineered Cells.
    Zhang R; Heyde KC; Scott FY; Paek SH; Ruder WC
    ACS Synth Biol; 2016 Sep; 5(9):936-41. PubMed ID: 27203116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic biology moving into the clinic.
    Ruder WC; Lu T; Collins JJ
    Science; 2011 Sep; 333(6047):1248-52. PubMed ID: 21885773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.